466 related articles for article (PubMed ID: 7527509)
1. Accumulation of the p53 tumor-suppressor gene product in oral leukoplakia.
Wood MW; Medina JE; Thompson GC; Houck JR; Min KW
Otolaryngol Head Neck Surg; 1994 Dec; 111(6):758-63. PubMed ID: 7527509
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of p53 is an early event in the tumorigenesis of oral squamous cell carcinomas.
Shintani S; Yoshihama Y; Emilio AR; Matsumura T
Anticancer Res; 1995; 15(2):305-8. PubMed ID: 7762998
[TBL] [Abstract][Full Text] [Related]
3. Markers of keratinocyte differentiation in snuff-induced leukoplakia.
Gilchrist JM; Thompson GC; Medina JE
Am J Surg; 1992 Dec; 164(6):563-6. PubMed ID: 1361105
[TBL] [Abstract][Full Text] [Related]
4. [Expressions of PDCD5 and p53 in oral leukoplakia and oral squamous cell carcinoma].
Zhao XY; Liu HW; Wei MJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 37(4):429-32. PubMed ID: 16086069
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of COX-2, EGFR, and p53 as biomarkers of non-dysplastic oral leukoplakias.
Prado SM; Cedrún JL; Rey RL; Villaamil VM; García AA; Ayerbes MV; Aparicio LA
Exp Mol Pathol; 2010 Oct; 89(2):197-203. PubMed ID: 20599939
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia.
Kurokawa H; Matsumoto S; Murata T; Yamashita Y; Tomoyose T; Zhang M; Fukuyama H; Takahashi T
J Oral Pathol Med; 2003 Oct; 32(9):513-21. PubMed ID: 12969225
[TBL] [Abstract][Full Text] [Related]
7. p53 expression in oral precancer and cancer.
Rich AM; Kerdpon D; Reade PC
Aust Dent J; 1999 Jun; 44(2):103-5. PubMed ID: 10452165
[TBL] [Abstract][Full Text] [Related]
8. Image analysis of p53 and cyclin D1 expression in premalignant lesions of the oral mucosa.
Liu SC; Hu Y; Sauter ER; Clapper ML; Chen SY; Lanfranchi HE; Engstrom PF; Klein-Szanto AJ
Anal Quant Cytol Histol; 1999 Apr; 21(2):166-73. PubMed ID: 10560487
[TBL] [Abstract][Full Text] [Related]
9. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
[TBL] [Abstract][Full Text] [Related]
10. Effect of snuff on cytokeratin expression in oral vestibular sulcus epithelium.
Luomanen M; Tiitta O; Heikinheimo K; Heinaro I; Happonen RP
J Oral Pathol Med; 1997 Mar; 26(3):110-6. PubMed ID: 9083934
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
Schaaij-Visser TB; Bremmer JF; Braakhuis BJ; Heck AJ; Slijper M; van der Waal I; Brakenhoff RH
Oral Oncol; 2010 Feb; 46(2):123-7. PubMed ID: 20036603
[TBL] [Abstract][Full Text] [Related]
12. Quantitative cell-cycle protein expression in oral cancer assessed by computer-assisted system.
Soares CP; Zuanon JA; Teresa DB; Fregonezi PA; Neto CB; Oliveira MR; Donadi EA; Martinelli-Kläy CP; Soares EG
Histol Histopathol; 2006 Jul; 21(7):721-8. PubMed ID: 16598671
[TBL] [Abstract][Full Text] [Related]
13. Mutated and wild-type p53 expression and HPV integration in proliferative verrucous leukoplakia and oral squamous cell carcinoma.
Gopalakrishnan R; Weghorst CM; Lehman TA; Calvert RJ; Bijur G; Sabourin CL; Mallery SR; Schuller DE; Stoner GD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Apr; 83(4):471-7. PubMed ID: 9127380
[TBL] [Abstract][Full Text] [Related]
14. p53 mutation and detection of p53 protein expression in oral leukoplakia and oral squamous cell carcinoma.
Ries JC; Schreiner D; Steininger H; Girod SC
Anticancer Res; 1998; 18(3B):2031-6. PubMed ID: 9677462
[TBL] [Abstract][Full Text] [Related]
15. Expression of the tumour suppressor gene p53 in oral cancer.
Langdon JD; Partridge M
Br J Oral Maxillofac Surg; 1992 Aug; 30(4):214-20. PubMed ID: 1380822
[TBL] [Abstract][Full Text] [Related]
16. Oral lichen planus has a high rate of TP53 mutations. A study of oral mucosa in icelanD.
Ogmundsdóttir HM; Hilmarsdóttir H; Astvaldsdóttir A; Jóhannsson JH; Holbrook WP
Eur J Oral Sci; 2002 Jun; 110(3):192-8. PubMed ID: 12120703
[TBL] [Abstract][Full Text] [Related]
17. [Immunohistochemical analysis of the p53 tumor suppressor gene product in oral leukoplakia].
Kikegawa A
Kokubyo Gakkai Zasshi; 2001 Mar; 68(1):51-9. PubMed ID: 11321806
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-alpha overexpression in proliferative verrucous leukoplakia and oral squamous cell carcinoma: an immunohistochemical study.
Kannan R; Bijur GN; Mallery SR; Beck FM; Sabourin CL; Jewell SD; Schuller DE; Stoner GD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1996 Jul; 82(1):69-74. PubMed ID: 8843456
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of p53, bcl-2, and Ki-67 immunoreactivity and of apoptosis in normal oral epithelium and in premalignant and malignant lesions of the oral cavity.
Piattelli A; Rubini C; Fioroni M; Iezzi G; Santinelli A
J Oral Maxillofac Surg; 2002 May; 60(5):532-40. PubMed ID: 11988932
[TBL] [Abstract][Full Text] [Related]
20. 8-Nitroguanine formation in oral leukoplakia, a premalignant lesion.
Ma N; Tagawa T; Hiraku Y; Murata M; Ding X; Kawanishi S
Nitric Oxide; 2006 Mar; 14(2):137-43. PubMed ID: 16290060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
